ZNF71
Endothelial zinc finger protein induced by tumor necrosis factor alpha
Also known as: Cos26, EZFIT, ZNF71_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NQZ8
- Gene
- ZNF71
- Ensembl
- ENSG00000197951
- Chromosome
- 19
- Canonical length
- 489 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
489 residues, UniProt reviewed canonical sequence.
>Q9NQZ8|ZNF71
1 MKELDPKNDI SEDKLSVVGE ATGGPTRNGA RGPGSEGVWE PGSWPERPRG DAGAEWEPLG
61 IPQGNKLLGG SVPACHELKA FANQGCVLVP PRLDDPTEKG ACPPVRRGKN FSSTSDLSKP
121 PMPCEEKKTY DCSECGKAFS RSSSLIKHQR IHTGEKPFEC DTCGKHFIER SSLTIHQRVH
181 TGEKPYACGD CGKAFSQRMN LTVHQRTHTG EKPYVCDVCG KAFRKTSSLT QHERIHTGEK
241 PYACGDCGKA FSQNMHLIVH QRTHTGEKPY VCPECGRAFS QNMHLTEHQR THTGEKPYAC
301 KECGKAFNKS SSLTLHQRNH TGEKPYVCGE CGKAFSQSSY LIQHQRFHIG VKPFECSECG
361 KAFSKNSSLT QHQRIHTGEK PYECYICKKH FTGRSSLIVH QIVHTGEKPY VCGECGKAFS
421 QSAYLIEHQR IHTGEKPYRC GQCGKSFIKN SSLTVHQRIH TGEKPYRCGE CGKTFSRNTN
481 LTRHLRIHTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF71 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 4.2 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 4.2 nTPM
- heart muscle: 4 nTPM
- colon: 3.7 nTPM
- blood vessel: 3.6 nTPM
- cerebellum: 3.5 nTPM
- cervix: 3.5 nTPM
Single-cell type
- podocytes: 9 nCPM
- distal convoluted tubule cells: 6 nCPM
- proximal tubule cells: 5.7 nCPM
- renal connecting tubule cells: 5.4 nCPM
- renal collecting duct intercalated cells: 5.3 nCPM
- loop of henle epithelial cells: 4.9 nCPM
Immune cell
- NK-cell: 6.1 nTPM
- MAIT T-cell: 4.5 nTPM
- gdT-cell: 4.3 nTPM
- T-reg: 3.8 nTPM
- memory CD8 T-cell: 3.6 nTPM
- naive B-cell: 3.6 nTPM
Brain region
- hippocampal formation: 17 nTPM
- cerebral cortex: 17 nTPM
- amygdala: 13 nTPM
- basal ganglia: 13 nTPM
- midbrain: 13 nTPM
- cerebellum: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.69
- DepMap mean gene effect
- 0.2
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF71 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF71 as an antibody target. Whether an autoantibody or antibody against ZNF71 could matter depends on whether native ZNF71 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF71 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF71 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...